Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 30, 2023
[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy]Yuhei Nakamura, Shunto Kawamura, Shimpei Matsumi, et al.
Transplantation and Cellular Therapy|August 29, 2023
Clinical Impact of Pretransplantation Physical Function on Transplantation after Allogeneic Hematopoietic Cell Transplantation in Older AdultsAyumi Gomyo, Shun-Ichi Kimura, Junko Suzuki, et al.
British Journal of Haematology|July 17, 2025
A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donorsYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
International Journal of Hematology|February 13, 2015
Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantationMiki Sato, Shinichi Kako, Kana Matsumoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2018
Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant SuccessKoji Kawamura, Hideki Nakasone, Saiko Kurosawa, et al.
Blood Advances|April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHDZachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 14, 2022
Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertensionYukiko Misaki, Daisuke Minakata, Tatsuro Ibe, et al.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Blood Immunology & Cellular Therapy|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRMYu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Pageof 11